Prevalence and Clinical Significance of Skin Manifestations in Parkinson Disease Patients
Keywords:
Parkinson's Disease, Dermatological Manifestations, Seborrheic Dermatitis, Xerosis, HyperhidrosisAbstract
Background: Parkinson's disease (PD) is primarily characterized by motor symptoms, but non-motor symptoms, including skin manifestations, are increasingly recognized. These remain underexplored despite their potential impact on quality of life.
Objectives: This study aimed to evaluate the prevalence and clinical features of skin findings in PD patients, with a focus on identifying potential pathogenetic links between dermatological conditions and PD.
Methods: A total of 215 PD patients were included. Comprehensive dermatological examinations were performed, and demographic and clinical data were collected. Statistical analysis was conducted using SPSS 23.0, with significance set at P < 0.05.
Results: Skin conditions were found in 92.1% of PD patients. Xerosis, seborrheic dermatitis, and hyperhidrosis were the most common findings. Pre-PD xerosis was associated with an earlier stage of PD (P = 0.001). Use of PD medications, such as levodopa/carbidopa/entacapone, was linked to a lower incidence of seborrheic dermatitis (P = 0.040). A significant correlation was also noted between rosacea and cherry angioma (P = 0.01).
Conclusion: Dermatological conditions are prevalent in PD and may precede its motor symptoms. Skin assessments could aid early diagnosis and management of PD, highlighting the need for further research on their pathogenetic mechanisms.
References
Ravn A-H, Thyssen JP, Egeberg A. Skin disorders in Parkinson’s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017;10:87-92. DOI:10.2147/CCID.S130319
Shah P, Sagar PR, Alhumaidi N, Bollampally VC, Malik BH. Parkinson’s Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis? Cureus. 2020;12(8):e9933. DOI:10.7759/cureus.9933
Shahid W, Satyjeet F, Kumari R, et al. Dermatological Manifestations of Parkinson’s Disease: Clues for Diagnosis. Cureus. 2020;12(10):e10836. DOI:10.7759/cureus.10836
Tomic S, Kuric I, Kuric TG, et al. Seborrheic Dermatitis Is Related to Motor Symptoms in Parkinson’s Disease. J Clin Neurol. 2022;18(6):628-634. DOI:10.3988/jcn.2022.18.6.628
Dinesh D, Lee JS, Gao X, Palacios N. Skin conditions in early Parkinson’s disease. Parkinsonism Relat Disord. 2021;84:40-46. DOI:10.1016/j.parkreldis.2021.01.018
Skorvanek M, Bhatia KP. The Skin and Parkinson’s Disease: Review of Clinical, Diagnostic, and Therapeutic Issues. Mov Disord Clin Pract. 2017;4(1):21-31. DOI:10.1002/mdc3.12425
Niemann N, Billnitzer A, Jankovic J. Parkinson’s disease and skin. Parkinsonism Relat Disord. 2021;82:61-76. DOI:10.1016/j.parkreldis.2020.11.017
Mathieu RJ, Guido N, Ibler E, et al. Rosacea and subsequent diagnosis for Parkinson’s disease: a large, urban, single center, US patient population retrospective study. J Eur Acad Dermatol Venereol. 2018;32(4):e141-e144. DOI:10.1111/jdv.14638
van Wamelen DJ, Leta V, Podlewska AM, et al. Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease. J Neurol. 2019;266(7):1736-1742. DOI:10.1007/s00415-019-09325-w
Scott GD, Lim MM, Drake MG, Woltjer R, Quinn JF. Onset of Skin, Gut, and Genitourinary Prodromal Parkinson’s Disease: A Study of 1.5 Million Veterans. Mov Disord. 2021;36(9):2094-2103. DOI:10.1002/mds.28636
Jucevičiūtė N, Banaitytė I, Vaitkus A, Balnytė R. Preclinical signs of Parkinson’s disease: A possible association of Parkinson’s disease with skin and hair features. Med Hypotheses. 2019;127:100-104. DOI:10.1016/j.mehy.2019.04.013
Zhang X, Guarin D, Mohammadzadehhonarvar N, Chen X, Gao X. Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants. BMJ Open. 2021;11(7):e046329. DOI:10.1136/bmjopen-2020-046329
Han Y, Wu D, Wang Y, Xie J, Zhang Z. Skin alpha-synuclein deposit patterns: A predictor of Parkinson’s disease subtypes. EBioMedicine. 2022;80:104076. DOI:10.1016/j.ebiom.2022.104076
Rodríguez-Leyva I, Calderón-Garcidueñas AL, Jiménez-Capdeville ME, et al. α-Synuclein inclusions in the skin of Parkinson’s disease and parkinsonism. Ann Clin Transl Neurol. 2014;1(7):471-478. DOI:10.1002/acn3.78
Wakabayashi K. Where and how alpha-synuclein pathology spreads in Parkinson’s disease. Neuropathology. 2020;40(5):415-425. DOI:10.1111/neup.12691
Pont-Sunyer C, Hotter A, Gaig C, et al. The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov Disord. 2015;30(2):229-237. DOI:10.1002/mds.26077
Martignoni E, Godi L, Pacchetti C, et al. Is seborrhea a sign of autonomic impairment in Parkinson’s disease? J Neural Transm. 1997;104(11-12):1295-1304. DOI:10.1007/BF01294730
Arsic Arsenijevic VS, Milobratovic D, Barac AM, Vekic B, Marinkovic J, Kostic VS. A laboratory-based study on patients with Parkinson’s disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production. BMC Dermatol. 2014;14:5. DOI:10.1186/1471-5945-14-5
Kohn SR, Pochi PE, Strauss JS, Sax DS, Feldman RG, Timberlake WH. Sebaceous gland secretion in Parkinson’s disease during L-dopa treatment. J Invest Dermatol. 1973;60(3). DOI:10.1111/1523-1747.ep12682040
Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Exploring the Association Between Rosacea and Parkinson Disease: A Danish Nationwide Cohort Study. JAMA Neurol. 2016;73(5):529-534. DOI:10.1001/jamaneurol.2016.0022
Fischer M, Gemende I, Marsch WC, Fischer PA. Skin function and skin disorders in Parkinson’s disease. J Neural Transm. 2001;108(2):205-213. DOI:10.1007/s007020170088
Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14(6):625-639. DOI:10.1016/S1474-4422(15)00007-1
Ferreira J, Silva JM, Freire R, et al. Skin cancers and precancerous lesions in Parkinson’s disease patients. Mov Disord. 2007;22(10):1471-1475. DOI:10.1002/mds.21575
Yaldiz M. Prevalence of actinic keratosis in patients attending the dermatology outpatient clinic. Medicine (Baltimore). 2019;98(28):e16465. DOI:10.1097/MD.0000000000016465.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ayşegül Yalçınkaya Iyidal, Funda Erduran, Yıldız Hayran, Yeşim Sücüllü Karadağ
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
